Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Idronoxil

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Idronoxil?

Idronoxil is an investigational drug.

There have been 6 clinical trials for Idronoxil. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2006.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Peritoneal Neoplasms, and Fallopian Tube Neoplasms. The leading clinical trial sponsors are Noxopharm Limited, National Cancer Institute (NCI), and Novogen Ltd.

Recent Clinical Trials for Idronoxil
A Study of Safety and Tolerability of NOX66 in Healthy VolunteersNoxopharm LimitedPhase 1
Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate CancerNoxopharm LimitedPhase 1
Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate CancerRoyal North Shore HospitalPhase 1

See all Idronoxil clinical trials

Clinical Trial Summary for Idronoxil

Top disease conditions for Idronoxil
Top clinical trial sponsors for Idronoxil

See all Idronoxil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.